Galletta Christopher bought TRVI
December 2, 2025 · Form 4 insider transaction
Galletta Christopher bought 4,225 shares of Trevi Therapeutics, Inc. at $0.51 per share, a transaction worth $2.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,225
Price
$0.51
Total value
$2.2K
InsiderGalletta Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 2, 2025
Filing dateDecember 3, 2025
Shares owned after26,095
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 6,870 shares purchased through the Issuer's employee stock purchase plan.